Robert E. Kibbelaar
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 10%
- Cancer-related Molecular Pathways
- Lung Cancer Research Studies
Papers in
- Genetics 3
- Chronic Lymphocytic Leukemia Research 3
-
- Immunodeficiency and Autoimmune Disorders 3
- Co-authors
- Otilia Dalesio (1 shared paper)Chris J.L.M. Meijer (1 shared paper)Johannes L. Bos (1 shared paper)Sjoerd Rodenhuis (1 shared paper)Nico van Zandwijk (1 shared paper)Robert J.C. Slebos (1 shared paper)Wolter J. Mooi (1 shared paper)A. Kooistra (1 shared paper)
- Journals
- European Journal of Radiology (1 paper)New England Journal of Medicine (1 paper)Leukemia (1 paper)Genes Chromosomes and Cancer (1 paper)Leukemia & lymphoma (1 paper)
- Partner nations
- Netherlands
In The Last Decade
Robert E. Kibbelaar
8 papers receiving 711 citations
Robert E. Kibbelaar's Hit Papers
Peers
Comparison fields: 5 of 64
- Pulmonary and Respiratory Medicine 408
- Oncology 304
- Cancer Research 159
- Pathology and Forensic Medicine 84
- Molecular Biology 277
Countries citing papers authored by Robert E. Kibbelaar
This map shows the geographic impact of Robert E. Kibbelaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Kibbelaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Kibbelaar more than expected).
Fields of papers citing papers by Robert E. Kibbelaar
This network shows the impact of papers produced by Robert E. Kibbelaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Kibbelaar. The network helps show where Robert E. Kibbelaar may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert E. Kibbelaar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | K-rasOncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung Hit paper breakdown → | 1990 | 712 |
| 2 | 1992 | 14 | |
| 3 | Hairy cell leukemia: an interphase cytogenetic study. | 1993 | 14 |
| 4 | 1997 | 10 | |
| 5 | 1992 | 5 | |
| 6 | Hairy cell leukemia | 1993 | 3 |
| 7 | 2008 | 2 | |
| 8 | 1991 | 1 |
About Robert E. Kibbelaar
Robert E. Kibbelaar is a scholar working on Genetics, Immunology, Hematology, Urology and Pulmonary and Respiratory Medicine, having authored 8 papers that have together received 761 indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Acute Myeloid Leukemia Research (2 papers), DNA and Nucleic Acid Chemistry (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Coronary Artery Anomalies (1 paper), Urological Disorders and Treatments (1 paper) and Aortic aneurysm repair treatments (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (408 citations), Oncology (304 citations), Cancer Research (159 citations), Pathology and Forensic Medicine (84 citations) and Molecular Biology (277 citations). Robert E. Kibbelaar has collaborated with scholars based in Netherlands. Frequent co-authors include Otilia Dalesio, Chris J.L.M. Meijer, Johannes L. Bos, Sjoerd Rodenhuis, Nico van Zandwijk, Robert J.C. Slebos, Wolter J. Mooi, A. Kooistra, Sjoerd Sc. Wagenaar and R.G.J.R.A. Vanderschueren. Their work appears in journals such as European Journal of Radiology, New England Journal of Medicine, Leukemia, Genes Chromosomes and Cancer and Leukemia & lymphoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.